Prascend Tablets 1mg For Horses 60 Tablets

Prascend is the first and only medicine available in the US that is fully approved by the FDA to treat pituitary pars intermedia dysfunction (more commonly called PPID or equine Cushing's disease) in horses. As part of the FDA approval process, Prascend was rigorously tested to prove its safety and effectiveness in reducing signs of PPID in horses.

When you treat your horse with Prascend under guidance from your veterinarian, you can rest assured that you're giving your equine friend a medicine that is tested and trusted to work safely and consistently. These study results really mean that you can feel confident giving your horse Prascend to control signs of PPID! It may help get your horse back to his healthy, happy self again.

Key Benefits

• Treats symptoms associated with Equine Cushing's Disease
• Improves quality of life

How It Works

Prascend contains the active ingredient, pergolide mesylate, which is a potent dopamine receptor agonist. It inhibits the release of prolactin, a hormone released by the pituitary gland. In horses with Equine Cushing's Disease, pergolide is believed to exert its therapeutic effect by stimulating dopamine receptors.

Indications

For the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (equine Cushing’s Disease) in horses.